Reported 2 days ago
Aristotle Capital Boston, LLC's recent investor letter highlighted Guardian Pharmacy Services (NYSE:GRDN) as a leading provider of pharmacy services in the U.S. for long-term care and behavioral health facilities. Despite showing modest gains, with a one-month return of 0.10% and YTD increase of 0.35%, the stock is currently not among the most popular with hedge funds. While its market position is strong amidst the aging population trend, the firm suggests that other AI stocks may offer better investment opportunities.
Source: YAHOO